These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 17668426)

  • 61. Engineered Nanoparticles for Effective Redox Signaling During Angiogenic and Antiangiogenic Therapy.
    Nethi SK; Barui AK; Mukherjee S; Patra CR
    Antioxid Redox Signal; 2019 Feb; 30(5):786-809. PubMed ID: 29943661
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Angiostatic and angiogenic factors.
    de Groot H; Schmit-Eilenberger V; Kirchhof J; Augustin AJ
    Dev Ophthalmol; 2010; 46():1-3. PubMed ID: 20703028
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Angiogenic factors and bladder cancer.
    Shao ZM; Nguyen M
    Front Biosci; 2002 Jan; 7():e33-5. PubMed ID: 11779705
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Diagnostic and Therapeutic Values of Angiogenic Factors in Endometrial Cancer.
    Roškar L; Roškar I; Rižner TL; Smrkolj Š
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053155
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Targeting TNF-alpha for cancer therapy.
    Burton ER; Libutti SK
    J Biol; 2009 Oct; 8(9):85. PubMed ID: 19863762
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combination of nanotechnology with vascular targeting agents for effective cancer therapy.
    Jahanban-Esfahlan R; Seidi K; Banimohamad-Shotorbani B; Jahanban-Esfahlan A; Yousefi B
    J Cell Physiol; 2018 Apr; 233(4):2982-2992. PubMed ID: 28608554
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene.
    Rastinejad F; Polverini PJ; Bouck NP
    Cell; 1989 Feb; 56(3):345-55. PubMed ID: 2464438
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anti-angiogenesis as a new concept for the therapy of neovascular diseases.
    Schweigerer L
    Klin Wochenschr; 1991 Jul; 69(10):417-8. PubMed ID: 1719269
    [No Abstract]   [Full Text] [Related]  

  • 69. Vascular mimicry: changing the therapeutic paradigms in cancer.
    Fathi Maroufi N; Taefehshokr S; Rashidi MR; Taefehshokr N; Khoshakhlagh M; Isazadeh A; Mokarizadeh N; Baradaran B; Nouri M
    Mol Biol Rep; 2020 Jun; 47(6):4749-4765. PubMed ID: 32424524
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The significance of SUMOylation of angiogenic factors in cancer progression.
    Wang M; Jiang X
    Cancer Biol Ther; 2019; 20(2):130-137. PubMed ID: 30261153
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nanomedicine for urologic cancers: diagnosis and management.
    Li C; Zeng X; Qiu S; Gu Y; Zhang Y
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):463-475. PubMed ID: 35660001
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Crucial Roles of microRNA-Mediated Autophagy in Urologic Malignancies.
    Shen M; Li X; Qian B; Wang Q; Lin S; Wu W; Zhu S; Zhu R; Zhao S
    Int J Biol Sci; 2021; 17(13):3356-3368. PubMed ID: 34512152
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunotherapy of urologic tumors: principles and progress.
    Broghammer EL; Ratliff TL
    Urol Oncol; 2002; 7(2):45-56. PubMed ID: 12474522
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Molecular signatures in urologic tumors.
    Larkin S; Kyprianou N
    Int J Mol Sci; 2013 Sep; 14(9):18421-36. PubMed ID: 24018887
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Angiosuppressive therapy for cancer.
    Fan TP
    Trends Pharmacol Sci; 1994 Feb; 15(2):33-6. PubMed ID: 7513100
    [No Abstract]   [Full Text] [Related]  

  • 76. Anti-angiogenesis: a multipurpose therapeutic tool?
    Ribatti D; Vacca A; Bertossi M; Roncali L
    Int J Clin Lab Res; 1993; 23(3):117-20. PubMed ID: 7691270
    [No Abstract]   [Full Text] [Related]  

  • 77. The use of microvessel density in assessing human urological tumours.
    Goddard JC; Sutton CD; Berry DP; O'Byrne KJ; Kockelbergh RC
    BJU Int; 2001 Jun; 87(9):866-75. PubMed ID: 11412229
    [No Abstract]   [Full Text] [Related]  

  • 78. Urology in the twenty-first century: noninvasive targeted treatments for urologic malignancies.
    Droller MJ
    World J Surg; 2000 Oct; 24(10):1211-4. PubMed ID: 11071464
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Growth factors in urologic tissues: detection, characterization, and clinical applications.
    Mydlo JH; Macchia RJ
    Urology; 1992 Dec; 40(6):491-8. PubMed ID: 1466100
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Multimodal Approach in the Diagnosis of Urologic Malignancies: Critical Assessment of ChatGPT-4V's Image-Reading Capabilities.
    Zhu L; Lai Y; Ta N; Cheng L; Chen R
    JCO Clin Cancer Inform; 2024 Apr; 8():e2300275. PubMed ID: 38593386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.